PHARMACYTE BIOTECH, INC. Operating Lease, Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Operating Lease, Expense of $28.37 thousand for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. operating lease, expense for the quarter ending 2026-04-30 was $6.97K, a 0.95% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating lease, expense for the quarter ending 2026-01-31 was $7.20K, a 1.77% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating lease, expense for the quarter ending 2025-10-31 was $7.08K, a 0.08% increase year-over-year.
- PHARMACYTE BIOTECH, INC. operating lease, expense for the quarter ending 2025-07-31 was $7.13K, a 1.10% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating lease, expense for fiscal 2026 was $28.37K, a 0.14% increase from fiscal 2025.
- PHARMACYTE BIOTECH, INC. operating lease, expense for fiscal 2025 was $28.34K, a 4.10% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. operating lease, expense for fiscal 2024 was $29.55K, a 26.16% increase from fiscal 2023.
- PHARMACYTE BIOTECH, INC. operating lease, expense for fiscal 2023 was $23.42K, a 21.09% increase from fiscal 2022.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | $6.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $14.17K derived: sum of 2 quarters · filed 2026-07-29 | $21.24K derived: sum of 3 quarters · filed 2026-07-29 | $28.37K 10-K · filed 2026-07-29 | |||
| 2026-01-31 | $7.20K 10-Q · filed 2026-03-17 | $14.27K derived: sum of 2 quarters · filed 2026-03-17 | $21.40K 10-Q · filed 2026-03-17 | $28.44K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-10-31 | $7.08K 10-Q · filed 2025-12-18 | $14.21K 10-Q · filed 2025-12-18 | $21.25K derived: sum of 3 quarters · filed 2026-07-29 | $28.32K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-07-31 | $7.13K 10-Q · filed 2025-09-15 | $14.17K derived: sum of 2 quarters · filed 2026-07-29 | $21.24K derived: sum of 3 quarters · filed 2026-07-29 | $28.31K derived: sum of 4 quarters · filed 2026-07-29 | |||
| 2025-04-30 | $7.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $14.11K derived: sum of 2 quarters · filed 2026-07-29 | $21.18K derived: sum of 3 quarters · filed 2026-07-29 | $28.34K 10-K · filed 2026-07-29 | |||
| 2025-01-31 | $7.07K 10-Q · filed 2026-03-17 | $7.02K 10-Q · filed 2025-03-17 | $14.14K derived: sum of 2 quarters · filed 2026-03-17 | $21.30K 10-Q · filed 2026-03-17 | $28.47K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-10-31 | $7.07K 10-Q · filed 2025-12-18 | $14.28K 10-Q · filed 2025-12-18 | $21.40K derived: sum of 3 quarters · filed 2025-12-18 | $28.23K derived: sum of 4 quarters · filed 2025-12-18 | |||
| 2024-07-31 | $7.21K 10-Q · filed 2025-09-15 | $14.33K derived: sum of 2 quarters · filed 2025-09-15 | $21.16K derived: sum of 3 quarters · filed 2025-09-15 | $27.79K derived: sum of 4 quarters · filed 2025-09-15 | |||
| 2024-04-30 | $7.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | $13.95K derived: sum of 2 quarters · filed 2025-08-11 | $20.58K derived: sum of 3 quarters · filed 2025-08-11 | $29.55K 10-K · filed 2025-08-11 | |||
| 2024-01-31 | $6.83K 10-Q · filed 2025-03-17 | $13.46K derived: sum of 2 quarters · filed 2025-03-17 | $22.42K 10-Q · filed 2025-03-17 | $28.80K derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-10-31 | $6.63K 10-Q · filed 2024-12-13 | $15.60K 10-Q · filed 2024-12-13 | $21.98K derived: sum of 3 quarters · filed 2024-12-13 | $27.77K derived: sum of 4 quarters · filed 2024-12-13 | |||
| 2023-07-31 | $8.97K 10-Q · filed 2024-09-17 | $15.35K derived: sum of 2 quarters · filed 2024-09-17 | $21.14K derived: sum of 3 quarters · filed 2024-09-17 | $26.89K derived: sum of 4 quarters · filed 2024-09-17 | |||
| 2023-04-30 | $6.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | $12.17K derived: sum of 2 quarters · filed 2024-08-13 | $17.93K derived: sum of 3 quarters · filed 2024-08-13 | $23.42K 10-K · filed 2024-08-13 | |||
| 2023-01-31 | $5.79K 10-Q · filed 2024-03-18 | $1.40K 10-Q · filed 2023-03-16 | $11.55K derived: sum of 2 quarters · filed 2024-03-18 | $17.04K 10-Q · filed 2024-03-18 | $6.10K 10-Q · filed 2023-03-16 | $18.00K derived: sum of 4 quarters · filed 2024-03-18 | |
| 2022-10-31 | $5.76K 10-Q · filed 2023-12-15 | $1.37K 10-Q · filed 2022-12-14 | $11.25K 10-Q · filed 2023-12-15 | $4.15K 10-Q · filed 2022-12-14 | $12.21K derived: sum of 3 quarters · filed 2023-12-15 | $16.07K derived: sum of 4 quarters · filed 2023-12-15 | |
| 2022-07-31 | $1.10K 10-Q · filed 2023-09-18 | $6.45K derived: sum of 2 quarters · filed 2023-09-18 | $10.31K derived: sum of 3 quarters · filed 2023-09-18 | $12.78K derived: sum of 4 quarters · filed 2023-09-18 | |||
| 2022-04-30 | $5.35K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | $9.21K derived: sum of 2 quarters · filed 2023-07-31 | $11.68K derived: sum of 3 quarters · filed 2023-07-31 | $19.34K 10-K · filed 2023-07-31 | |||
| 2022-01-31 | $3.87K 10-Q · filed 2023-03-16 | $6.10K 10-Q · filed 2022-03-15 | $6.34K derived: sum of 2 quarters · filed 2023-03-16 | $13.99K 10-Q · filed 2023-03-16 | $12.68K derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-10-31 | $2.47K 10-Q · filed 2022-12-14 | $4.15K 10-Q · filed 2021-12-14 | $7.89K 10-Q · filed 2022-12-14 | $8.81K derived: sum of 3 quarters · filed 2022-12-14 | $14.10K derived: sum of 4 quarters · filed 2022-12-14 | ||
| 2021-07-31 | $3.74K 10-Q · filed 2022-09-14 | $6.34K derived: sum of 2 quarters · filed 2022-09-14 | $11.63K derived: sum of 3 quarters · filed 2022-09-14 | $17.02K derived: sum of 4 quarters · filed 2022-09-14 | |||
| 2021-04-30 | $2.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $7.89K derived: sum of 2 quarters · filed 2022-07-28 | $13.28K derived: sum of 3 quarters · filed 2022-07-28 | $20.43K 10-K · filed 2022-07-28 | |||
| 2021-01-31 | $5.29K 10-Q · filed 2022-03-15 | $10.67K derived: sum of 2 quarters · filed 2022-03-15 | $17.82K 10-Q · filed 2022-03-15 | $24.98K derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-10-31 | $5.38K 10-Q · filed 2021-12-14 | $12.54K 10-Q · filed 2021-12-14 | $19.69K derived: sum of 3 quarters · filed 2021-12-14 | $26.84K derived: sum of 4 quarters · filed 2021-12-14 | |||
| 2020-07-31 | $7.15K 10-Q · filed 2021-09-14 | $14.30K derived: sum of 2 quarters · filed 2021-09-14 | $21.46K derived: sum of 3 quarters · filed 2021-09-14 | $29.45K derived: sum of 4 quarters · filed 2021-09-14 | |||
| 2020-04-30 | $7.15K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | $14.30K derived: sum of 2 quarters · filed 2021-08-10 | $22.30K derived: sum of 3 quarters · filed 2021-08-10 | $30.96K 10-K · filed 2021-08-10 | |||
| 2020-01-31 | $7.15K 10-Q · filed 2021-03-12 | $15.15K derived: sum of 2 quarters · filed 2021-03-12 | $23.81K 10-Q · filed 2021-03-12 | $32.97K derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-10-31 | $8.00K 10-Q · filed 2020-12-11 | $16.66K 10-Q · filed 2020-12-11 | $25.81K derived: sum of 3 quarters · filed 2020-12-11 | $34.81K derived: sum of 4 quarters · filed 2020-12-11 | |||
| 2019-07-31 | $8.66K 10-Q · filed 2020-09-11 | $17.81K derived: sum of 2 quarters · filed 2020-09-11 | $26.81K derived: sum of 3 quarters · filed 2020-09-11 | $35.81K derived: sum of 4 quarters · filed 2020-09-11 | |||
| 2019-04-30 | $9.15K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $18.15K derived: sum of 2 quarters · filed 2020-08-13 | $27.15K derived: sum of 3 quarters · filed 2020-08-13 | $34.15K 10-K · filed 2020-08-13 | |||
| 2019-01-31 | $9.00K 10-Q · filed 2019-03-14 | $18.00K derived: sum of 2 quarters · filed 2019-03-14 | $25.00K 10-Q · filed 2019-03-14 | $35.21K derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-10-31 | $9.00K 10-Q · filed 2018-12-14 | $17.00K 10-Q · filed 2018-12-14 | $26.21K derived: sum of 3 quarters · filed 2019-09-13 | $35.21K derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-07-31 | $8.33K 10-Q · filed 2019-09-13 | $17.21K derived: sum of 2 quarters · filed 2019-09-13 | $26.21K derived: sum of 3 quarters · filed 2019-09-13 | $35.21K derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-04-30 | $8.88K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $17.88K derived: sum of 2 quarters · filed 2019-08-13 | $26.88K derived: sum of 3 quarters · filed 2019-08-13 | $33.88K 10-K · filed 2019-08-13 | |||
| 2018-01-31 | $9.00K 10-Q · filed 2019-03-14 | $8.33K 10-Q · filed 2018-03-19 | $18.00K derived: sum of 2 quarters · filed 2019-03-14 | $25.00K 10-Q · filed 2019-03-14 | $25.15K 10-Q · filed 2018-03-19 | ||
| 2017-10-31 | $9.00K 10-Q · filed 2018-12-14 | $17.00K 10-Q · filed 2018-12-14 | |||||
| 2017-07-31 | $8.22K 10-Q · filed 2018-09-12 | ||||||
| 2017-01-31 | $13.70K 10-Q · filed 2018-03-19 | $37.13K 10-Q · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |